Medscape Newsfeed:
- FDA Approves First-In-Class Med for Parkinson's Disease
Today's FDA approval of tavapadon makes it the first selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease. Medscape Medical News
- MHT Thrombotic Risks Differ by Route, Dose, and Duration
Experts highlight the importance of an individualized approach to care. Medscape Medical News
- From Bubble Boy to Gene Therapy: A New Era for IEIs
Faster, cheaper genetic tests are helping researchers identify mutations behind hundreds of these disorders, leading to improved diagnosis and treatment. Medscape Medical News
- One-Leg Cycling Beats Two-Leg Cycling for Endurance in IPF
Patients with idiopathic pulmonary fibrosis who train by cycling one leg at a time during rehabilitation gain more exercise endurance than those who cycle with both legs together, a trial shows. Medscape Medical News
- Is Rozanolixizumab Effective in Severe Fibromyalgia?
In patients with severe fibromyalgia, rozanolixizumab may reduce the impact of the condition on health and function but may not improve pain intensity or fatigue. Medscape Medical News
NIH Newsfeed:
- NIH launches new PubMed tool to strengthen research replication and reproducibility
Linked Discoveries is an experimental tool to help scientists see how individual research findings relate to the larger body of biomedical evidence.
- Modified HIV drug reverses vision loss and paralysis in multiple sclerosis model
Modified HIV drug reverses vision loss and paralysis in multiple sclerosis model.
- Scientists develop high-resolution molecular maps of Alzheimer’s and related brain disorders
NIH-funded effort delivers new insights into symptoms and underlying mechanisms of these conditions to improve prevention, detection, treatment, and outcomes.
- NIH makes major investments to advance human-based research infrastructure and technologies
Projects spanning the nation will accelerate scientific discovery, reduce reliance on animals.